Vaccines against SARS-CoV-2 are one of the main mechanisms of exit from the pandemic. Respiratory teams need to understand new developments in immunology and vaccine design, and the importance and complexities of new vaccine regulation.
An understanding of the immunology of vaccine response and subsequent immunity, and the role of the regulator in vaccine approval.
Clinicians, Trainees, Nurses, AHPs, Basic scientists, Public health teams, Policy makers etc.
- Introduction from the Chairs - 2 minutes
- Anita Simonds (ERS President), Tobias Welte (ERS Past President)
- Vaccines and regulation - what have we learnt, what's the future - 18 minutes
- Marco Cavaleri (Head of Anti-infectives and Vaccines, European Medicines Agency, Amsterdam, Netherlands)
- The immune response to SARS-Cov-2 infection and vaccines - 18 minutes
- Rosemary Boyton (Head of Lung Immunology, Adult Infectious Disease, Imperial College, London, United Kingdom)
- Q&A - 20 minutes
- Closing remarks and wrap-up - 2 minutes
2 lectures and Q&A
- Vaccine trials, steps in regulatory process
- Efficacy, effectiveness and safety of vaccines
- Immunology of vaccines response.
Following this course, participants should be able to:
- Describe the regulatory process used for approval of new vaccines, the analysis of trial data, and the immunology of vaccine response in different populations.
ERS has applied for an accreditation of this webinar by the European Board for Accreditation in Pneumology (EBAP), 1 CME credit per 1-hour attendance. In case of acceptance, CME credit will be granted upon attendance during the LIVE webinar. Accreditation results will be presented here in the upcoming days.
What is a webinar?
The webinar closely simulates a lecture-based teaching experience. The speaker can interact with the audience, just as in a classroom setting.
This webinar comprises 45-minute lecture followed by a 15-minute question-and-answer sessions. During the webinar you will be asked to share your opinion on issues related to the topic using interactive polls.
All participants will be able to hear the lecturer and see the slides throughout the presentation. As a participant you will be able to pose questions or discuss ideas with the other participants via the text chat facility and the speaker will respond to the questions via the microphone.
More information will be communicated in due course.
- Please log in to the webinar 20 minutes before it is scheduled to commence. If you have any technical difficulties whilst trying to log in or during the session please contact email@example.com
- Check Central European Time.
- To achieve the best quality, we recommend to stop all other programmes and to avoid downloading anything from the internet during your connection to the lecture.
- Please also ensure that your audio settings are not set to mute and adjust the volume to a comfortable level.